BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
31 hedge funds and large institutions have $9.43M invested in Baudax Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
4
Closed
13
Calls
$899K
Puts
$105K
Net Calls
+$794K
Net Calls Change
+$734K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.38M |
2 |
BlackRock
New York
|
+$1.64M |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$433K |
4 |
Two Sigma Advisers
New York
|
+$171K |
5 |
Northern Trust
Chicago,
Illinois
|
+$135K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$3.54M |
2 |
Renaissance Technologies
New York
|
-$426K |
3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$268K |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$181K |
5 |
D.E. Shaw & Co
New York
|
-$134K |